Drug Type AAV based gene therapy |
Synonyms |
Target |
Mechanism SOD1 inhibitors(Superoxide dismutase inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization Arbor Biotechnologies, Inc.Startup |
Active Organization Arbor Biotechnologies, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Discovery | US | Arbor Biotechnologies, Inc.Startup | 27 Feb 2024 |